On March 6th, Li Hongjun, member of the Standing Committee of the Jiangxi Provincial Party Committee and Secretary of the Nanchang Municipal Party Committee, went to the High tech Zone to conduct research on Jiangxi Saiji Biotechnology, understand the development situation of the enterprise, listen to the report of the enterprise leader, and coordinate to solve the difficulties encountered by the enterprise in its development; Wang Wanzheng, member of the Standing Committee of the Nanchang Municipal Party Committee, Vice Mayor Xiao Yun, member of the Standing Committee of the Nanchang Municipal Party Committee, and Secretary of the Party Working Committee of the Nanchang High tech Zone, attended.3月6日，

Chairman Chen Shanwen introduced the development history, product research and development direction, and future plans of Saiji Biotechnology.

Jiangxi Saiji Biotechnology Co., Ltd. focuses on life science research and clinical applications. Currently, the company focuses on a new flow cytometry immune platform and has become an absolute leading brand in the field of flow cytometry in the domestic in vitro diagnostic industry. More than 80% of its research and development products are domestically pioneering products. After 7 years of efforts and development, Saiji Biotechnology has obtained multiple honors such as high-tech enterprise certification, "Top 10 High Growth Enterprises", and "Specialized, Refined, Special, and New" small and medium-sized enterprises in Nanchang, Jiangxi Province. The company's products serve more than 500 tertiary hospitals nationwide, forming an upstream and downstream ecological industry chain from raw material research and development, instrument manufacturing, reagent research and development, registration, to production and sales

Secretary Li Hongjun and his delegation visited Saiji Biotechnology

Secretary Li Hongjun walked into the production area, quality control room, and research and development area of the enterprise to inspect the production and operation, product research and development, and other situations of the enterprise. He had in-depth exchanges with the enterprise leaders and urged the enterprise to continue to focus on high-tech and high-value fields, accelerate the optimization and upgrading of product production lines, enhance independent equipment research and development capabilities, promote technological innovation related to the industrial chain, and further enhance the core competitiveness of the enterprise.